Ferring Pharmaceuticals SA Rep Office Middle East
$313.53 3 recipients
Compare payment profiles
CMS Open Payments · Program Year 2024
DTE Oregon, Inc.
DTE Oregon, Inc. reported $304.57 across General Payments, Research, and Ownership to 3 physicians and teaching hospitals across 3 transactions.
- $304.57 Below-median payer
- All-tracks total
- 3 Below-median volume
- Transactions
- 3 Below-median reach
- Recipients
- +$167.77
- General Payments vs PY2023
DTE Oregon, Inc. reported $304.57 across all CMS Open Payments tracks (General + Research + Ownership) to 3 physicians and teaching hospitals in Program Year 2024 - ranking #1889 of 1,925 reporting manufacturers (0.0% of the all-tracks industry total); General Payments alone were $304.57, averaging $101.52 per recipient.
DTE Oregon, Inc.'s payment reach score
Each tracked dimension is percentile-scored against the national companies corpus, then averaged across only the dimensions that apply to this company, a neutral scale measure of reporting activity, not a rating of quality, safety, or ethics.
Overall reach score
F
13/100
Total payments
F
10/100
Transaction volume
F
10/100
Physician reach
F
10/100
Payment type diversity
F
23/100
Data currency: Figures are rendered from the processed CMS Open Payments release. See our methodology for source dates and refresh cadence. Spot a figure that looks wrong? Report a correction.
CMS Sunshine Act warrant
Manufacturer dte-oregon-inc DTE Oregon, Inc.
$304.57 · #1889/1,925 · 0.0% industry · PY2024
- TOT $304.57
- RANK #1889
- SHARE 0.0%
- TXN 3
- RCP 3
- CAT 2
- GEN $304.57
- ΔGEN +$167.77
- TOP1 43.8%
- PY 2024
Volume peers
Nearest volume peer: Ferring Pharmaceuticals SA Rep Office Middle East ($313.53)
DTE Oregon, Inc. sits among 1,925 manufacturers disclosing under the Physician Payments Sunshine Act. Volume peers below are nearest by all-tracks total, not corporate affiliates. Open the company rankings →
Release-over-release change
General Payments changed from PY2023 to PY2024
DTE Oregon, Inc.'s CMS-reported General Payments increased by $167.77 (+122.6%) from PY2023 to PY2024.
How this year-over-year comparison is scoped
The comparison uses consecutive CMS program years only (current = prior + 1) from the manufacturer General Payments summary and excludes research and ownership or investment records. Non-consecutive year pairs are not shown as year-over-year change. This General Payments figure is not the all-tracks company total in the hero.
CMS source labels for this exact identifier: PY2022: DTE OREGON, INC.PY2023: DTE OREGON, INC.PY2024: DTE Oregon, Inc.. Matching identifiers support a bounded record comparison; a label difference would be reported as unresolved rather than treated as a corporate event.
Subscribe to this company's source-bounded update feed It publishes only identifier-matched CMS release comparisons, never inferred company events.
General Payments: PY2023 vs PY2024
Annual CMS-reported totals for this company, not an all-category Open Payments total
- PY2023
- $136.80
- PY2024
- $304.57
What the Data Shows for DTE Oregon, Inc.
Three separate CMS disclosure tracks feed the all-tracks total above - General, Research, and Ownership/Investment - each reported under its own rules and combined here for one comparable figure. For DTE Oregon, Inc. that figure is drawn almost entirely from the General Payments track (day-to-day consulting, meals, travel and speaking fees). CMS releases each Program Year roughly 12 months after it ends; the methodology page covers the full standardization basis.
"Food and Beverage" leads the 2-category general-payment breakdown below at $171.24 (56.2% of General Payments, 2 transactions) - see our methodology for how research and ownership payments are reported separately.
General Payment Breakdown by Type
"Food and Beverage" leads DTE Oregon, Inc.'s 2-category general-payment breakdown at $171.24, 56.2% of the reported total.
How DTE Oregon, Inc. divides its payments
How the reported total splits across payment categories
| Payment Type | Amount | Transactions | % of Total |
|---|---|---|---|
| Food and Beverage | $171.24 | 2 | 56.2% |
| Entertainment | $133.33 | 1 | 43.8% |
Recipient Concentration in General Payments
The five largest recipient relationships account for $304.57 (100.0%) of $304.57 in this company's General Payments records across 3 recipients.
General Payments scope note
Program Year 2024 General Payments view only: excludes research and ownership/investment records, so it is not the all-category company total above.
Largest General-Payment relationships for DTE Oregon, Inc.
The five named recipients with the highest reported General Payments from this company
- 1
Chad Duplantis
$133.33 across 1 reported transactions
- 2
Vishal Pattni
$85.62 across 1 reported transactions
- 3
Saumeen Desai
$85.62 across 1 reported transactions
Compare this company's payment profile with similarly sized manufacturers in the company comparison tool, and consult the methodology for the CMS source scope.
Spend vs. Concentration
DTE Oregon, Inc. ranks #1889 of 1,925 by total payments (bottom 2% by spend) but is notably more concentrated than that alone would suggest -- #503 of 1,838 by HHI (top 27% most concentrated). Its payments land on an unusually narrow set of recipients for its spend size.
View all 12 companies in this HHI neighborhood as a list
- Fresenius Kabi USA, LLC : $1.3M total payments, HHI 3555
- Immunocore Limited : $1.1M total payments, HHI 3543
- GastroGPO, LLC : $3.7K total payments, HHI 3528
- Pfizer Chile S.a. : $16.9K total payments, HHI 3528
- Verathon Inc. : $672.8K total payments, HHI 3520
- J. Morita USA, Inc. : $88.2K total payments, HHI 3500
- DTE Oregon, Inc. (this company) : $304.57 total payments, HHI 3497
- Alcon Research LLC : $7.1M total payments, HHI 3482
- Winter Innovations, Inc. : $4.7K total payments, HHI 3468
- ONY Biotech Inc. : $39.6K total payments, HHI 3464
- Cardinal Health 110 LLC : $92.3K total payments, HHI 3463
- Agile Therapeutics, Inc. : $131.2K total payments, HHI 3462
Similarly Concentrated Companies
Companies whose General Payments are spread across recipients about as (un)evenly as DTE Oregon, Inc.'s, measured by the same HHI concentration index above, not by payment size.
What HHI 2,500 means here
2,500 is the DOJ/FTC merger-guidelines threshold for "highly concentrated" markets; used here only as a familiar concentration reference, not a legal finding about DTE Oregon, Inc..
Companies with Similar Payment Volumes
Open a profile or compare a similar company's CMS-reported payment pattern with DTE Oregon, Inc..
Showing 6 of 1,924 companies with CMS-reported payment data.
Quest Medical Inc.
$314.09 4 recipients
Compare payment profiles
Owens & Minor Distribution, Inc.
$316.70 4 recipients
Compare payment profiles
Teleflex Medical Canada Inc.
$289.56 1 recipients
Compare payment profiles
Materialise USA LLC
$273.65 6 recipients
Compare payment profiles
Ricoh USA, Inc.
$336.00 6 recipients
Compare payment profiles
Put this to use
DTE Oregon, Inc. ranks #1889 of 1,925 by all-tracks total payments, led by "Food and Beverage".
- See how manufacturer spending compares across the full leaderboard. Top 100 by total payments
- Compare "Food and Beverage" spend across every manufacturer, not just DTE Oregon, Inc.. Payment type breakdowns
- New to Open Payments? Learn what these figures do and do not show. Read the guide
Reported payments reflect what companies disclosed to CMS; a payment is not evidence of wrongdoing.
Data sourced from CMS Open Payments (Physician Payments Sunshine Act). See our methodology for details. Retrieved and formatted by PlainPharmaWatch
Disclaimer
This information is provided for informational purposes only and does not constitute professional advice. Data is sourced from the CMS Open Payments program. Consult a qualified professional before making decisions based on this data.
Read our methodology - how this data is sourced, computed, and verified.
Every figure on PlainPharmaWatch is rendered directly from federal source data, no number is typed in by an editor. This page draws directly on federal source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of 2026-07-26.